Gemini Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GMTX and other ETFs, options, and stocks.

About GMTX

Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. 

CEO
Georges Gemayel
CEOGeorges Gemayel
Employees
33
Employees33
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
33
Employees33

GMTX Key Statistics

Market cap
64.00M
Market cap64.00M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
157.53K
Average volume157.53K
High today
$1.50
High today$1.50
Low today
$1.41
Low today$1.41
Open price
$1.41
Open price$1.41
Volume
41.77K
Volume41.77K
52 Week high
$4.47
52 Week high$4.47
52 Week low
$1.16
52 Week low$1.16

GMTX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.